Ticker Details
Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
IPO Date:	January 2, 1990
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$952.34B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.99 | 0.95%
Avg Daily Range (30 D):	$15.78 | 1.50%
Avg Daily Range (90 D):	$14.42 | 1.44%

Institutional Daily Volume
Avg Daily Volume:	4.33M
Avg Daily Volume (30 D):	2.75M
Avg Daily Volume (90 D):	2.87M

Trade Size
Avg Trade Size (Sh.):	114
Avg Trade Size (Sh.) (30 D):	21
Avg Trade Size (Sh.) (90 D):	21

Institutional Trades
Total Institutional Trades:	87,329
Avg Institutional Trade:	$10.01M
Avg Institutional Trade (30 D):	$108.99M
Avg Institutional Trade (90 D):	$99.72M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	15

Market Closing Trades
Avg Closing Trade:	$89.91M
Avg Closing Trade (30 D):	$471.5M
Avg Closing Trade (90 D):	$453.15M
Avg Closing Volume:	415.01K

News

Feb 24, 2026 @ 11:00 AM Novo Nordisk's China Obesity Drug Cuts Nearly One-... Source: Vandana Singh

Feb 24, 2026 @ 1:30 AM Got $5,000? Viking Therapeutics Might Be a WeightÃ... Source: Prosper Junior Bakiny

Feb 23, 2026 @ 10:21 PM Stock Market Today, Feb. 23: Novo Nordisk Plunges ... Source: Emma Newbery

Feb 23, 2026 @ 9:37 PM 1 Reason I'd Buy Veeva Systems Stock and Never Sel... Source: Prosper Junior Bakiny

Feb 23, 2026 @ 7:29 PM Viking Therapeutics Stock Gains Amid Obesity Drug ... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$23	$7.4	$23
Diluted EPS	$22.95	$7.39	$22.95
Revenue	$65.18B	$19.29B	$65.18B
Gross Profit	$54.13B	$15.92B	$54.13B
Net Income / Loss	$20.64B	$6.64B	$20.64B
Operating Income / Loss	$25.73B	$8.27B	$25.73B
Cost of Revenue	$11.05B	$3.37B	$11.05B
Net Cash Flow	$4B	$-2523.5M	$4B
PE Ratio	45.45